StockData
Abbott Laboratories logo

Abbott Laboratories (ABT) operating KPIs

ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)

Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%

Abbott Laboratories capital Expenditures ($M) ($M)

Postgres DB financial_values + XBRL

QuarterlyAnnual
Latest, Q2 2026
497
Period ended Jun 30, 2026
Change on a year earlier
-1.0%
502 in Q2 2025
History
72 quarters
Since Q3 2008
Sources
63
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedCapital Expenditures ($M) ($M)Year on yearSource
Q2 2026Jun 30, 2026497-1.0%Form 10-Q (filed 2026-07-28) ↗
Q1 2026Mar 31, 2026399-17.6%Form 10-Q (filed 2026-04-29) ↗
Q4 2025Dec 31, 2025689-4.3%Form 10-K (filed 2026-02-20) ↗
Q3 2025Sep 30, 2025496-10.8%Form 10-Q (filed 2025-10-29) ↗
Q2 2025Jun 30, 2025502-5.8%Form 10-Q (filed 2025-07-30) ↗
Q1 2025Mar 31, 2025484+21.6%Form 10-Q (filed 2025-04-30) ↗
Q4 2024Dec 31, 2024720-4.6%Form 10-K (filed 2025-02-21) ↗
Q3 2024Sep 30, 2024556-0.7%Form 10-Q (filed 2024-10-31) ↗
Q2 2024Jun 30, 2024533+5.1%Form 10-Q (filed 2024-07-31) ↗
Q1 2024Mar 31, 2024398+4.7%Form 10-Q (filed 2024-05-02) ↗
Q4 2023Dec 31, 2023755+23.8%Form 10-K (filed 2024-02-16) ↗
Q3 2023Sep 30, 2023560+19.9%Form 10-Q (filed 2023-11-01) ↗
Q2 2023Jun 30, 2023507+33.8%Form 10-Q (filed 2023-08-03) ↗
Q1 2023Mar 31, 2023380+18.4%Form 10-Q (filed 2023-05-04) ↗
Q4 2022Dec 31, 2022610-0.7%Form 10-K (filed 2023-02-17) ↗
Q3 2022Sep 30, 2022467+1.3%Form 10-Q (filed 2022-11-01) ↗

Cite this data

StockData. (2026). Abbott Laboratories Capital Expenditures ($M) ($M), quarterly Q3 2008–Q2 2026 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/db-cf-capex

See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.